Decode Aging. Design Longevity.
Advanced Epigenetic Analytics for Aging & Longevity Innovation
Turn DNA Methylation into Actionable Longevity Insights.
At EpiDisease, we help longevity innovators transform raw DNA methylation data into clinically meaningful biological aging metrics.
Our core expertise lies in high-resolution methylation analysis using the Illumina EPIC array platform, enabling scalable, research-grade epigenetic profiling for:
Longevity R&D
Biomarker development
Intervention validation
Performance assessment
Biological age tracking
Whether you are building next-generation diagnostics, longevity therapeutics, wellness solutions, or cosmetic aging claims, we provide the epigenetic backbone to accelerate your roadmap.
Comprehensive DNA Methylation Clock Portfolio
We support calculation and interpretation of a broad suite of established and next-generation DNAm clocks, covering chronological age, biological aging, functional decline, and longevity risk.
Chronological DNAm Age
Horvath’s Clock
Hannum’s Clock
Horvath Skin & Blood
Reliable estimation of chronological age across tissues and cohorts.
Biological & Functional Aging
- PhenoAge (Levine’s Clock)
- GrimAge
- GrimAge2
- DNAmFitAge
Designed to capture healthspan, mortality risk, physiological decline, and intervention responsiveness — ideal for longevity studies and anti-aging validation.
Emerging Next-Generation Clocks
- Chen’s Clock
- Zhang’s Clock
Advanced models for deeper biological aging stratification and exploratory longevity research.
Gestational DNAm Age (Optional Modules)
- Knight’s Clock
- Bohlin’s Clock
- Mayne’s Clock
- Lee’s Clocks
- Chen’s Clock
Supporting developmental biology, early-life programming, and perinatal research.
Why Partner with EpiDisease?
Longevity-focused epigenetics expertise
We specialize in aging biology and translational epigenomics — not generic genomics.
EPIC end-to-end pipelines with Illumina arrays
From raw IDAT files to QC, normalization, clock computation, and interpretation.
Research-grade rigor, industry-ready outputs
Built for biotech, diagnostics, wellness, and cosmetic longevity programs.
Custom analytics & reporting
Cohort comparisons, intervention impact, biological age deltas, and executive-ready reports aligned with your business objectives.
From Methylation Data to Longevity Strategy
We don’t just generate epigenetic readouts.
We help you translate methylation signals into product decisions, R&D validation, and biological age optimization strategies.
Our clients use EpiDisease to:
Validate anti-aging interventions
Develop epigenetic biomarkers
Support longevity claims
Stratify clinical or consumer cohorts
Quantify biological age change over time
All supported by reproducible pipelines and deep domain expertise.


